When do you send for genetic testing (e.g., SPINK1, PRSS1, CFTR) in a patient with recurrent or chronic pancreatitis without an obvious etiology and how does it impact your management?

I offer and discuss getting genetic testing in patients with idiopathic recurrent acute pancreatitis or chronic pancreatitis, more frequently in younger patients. Impact of testing can help identify undiagnosed CFTR patients, for whom further CF evaluation and management including options to try new...

Send genetic testing in younger patients who have acute recurrent pancreatitis/CP.

Regarding change in management, we of course can’t ‘cure’ their genetic disorder right now but will at least have a reason for why they keep getting the attacks. And if the patient has hereditary pancreatitis, they’re...